TOPICAL AVASTIN EFFECTIVE FOR CORNEAL NEOVASCULARIZATION

Arch Ophthalmol -- Abstract: Topical Bevacizumab in the Treatment of Corneal Neovascularization: Results of a Prospective, Open-Label, Noncomparative Study, April 2009, Dastjerdi et al. 127 (4): 381:


"Short-term topical bevacizumab therapy reduces the severity of corneal NV without local or systemic adverse effects."